title: Modulation of intracellular calcium levels inhibits secretion of collagenase 1 by migrating keratinocytes.
abstract: Calcium concentration influences keratinocyte differentiation, and, following injury, keratinocytes move through an environment of changing calcium levels. Because these migrating cells in wounds invariably express collagenase 1, we assessed if modulation of calcium levels regulates collagenase 1 production by primary human keratinocytes. Accurately reflecting the confined spatial pattern of enzyme production seen in vivo, collagenase 1 mRNA was expressed only by keratinocytes migrating from foci of differentiated cells. Treatment with calcium ionophores A23187 or thapsigargin markedly inhibited the basal and phorbol 12-myristate 13-acetate-(PMA) stimulated accumulation of keratinocyte collagenase 1 in the medium but did not affect collagenase 1 production by control or PMA-treated fibroblasts. A23187-mediated inhibition of collagenase 1 protein was not associated with a decrease in mRNA levels but rather was controlled by a selective and reversible block of enzyme secretion. This block in secretion was likely not due to altered protein folding as the proenzyme within A23187-treated cells remained capable of autolytic activation upon treatment with p-aminophenylmercuric acetate. In contrast, 92-kDa gelatinase mRNA and secreted protein levels were coordinately reduced by A23187. Keratin 14 expression, a basal keratinocyte marker, was reduced with PMA treatment, but A23187 did not affect keratin 14 expression. In human wounds, both basal and suprabasal keratinocytes at the migrating front of epidermis stained for keratin 14, but only the basal cells expressed collagenase 1. These data suggest that collagenase 1 production is not necessarily linked with expression of basal cell markers and that modulation of intracellular calcium levels can block secretion of collagenase 1 by keratinocytes which have moved away from the stratum basalis and from their natural substrate.
authors.affiliation: Department of Medicine (Dermatology), Washington University School of Medicine, St Louis, Missouri 63110, USA.
authors.forename: B D
authors.initials: BD
authors.lastname: Sudbeck
authors.forename: B K
authors.initials: BK
authors.lastname: Pilcher
authors.forename: A P
authors.initials: AP
authors.lastname: Pentland
authors.forename: W C
authors.initials: WC
authors.lastname: Parks
mesh_terms: D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002454:Cell Differentiation; D002465:Cell Movement; D002478:Cells, Cultured; D017364:Collagenases / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007476:Ionophores / Q000494:pharmacology; D015603:Keratinocytes / Q000166:cytology / Q000187:drug effects / Q000201:enzymology*; D020781:Matrix Metalloproteinase 1; D061965:Matrix Metalloproteinase Inhibitors; D012333:RNA, Messenger / Q000378:metabolism; D019284:Thapsigargin
chemical_list: D007476:Ionophores; D061965:Matrix Metalloproteinase Inhibitors; D012333:RNA, Messenger; D000001:Calcimycin; D019284:Thapsigargin; D017364:Collagenases; D020781:Matrix Metalloproteinase 1; D002118:Calcium